{"url_path":"/sec/cero/8-k/2026-06-26/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 Creation of a Direct Financial Obligation","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/1870404/0001213900-26-072602-index.html","accession_number":"0001213900-26-072602","cik":"0001870404","ticker":"CERO","issuer_name":"CERO THERAPEUTICS HOLDINGS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1870404/0001213900-26-072602-index.html","primary_entity_key":"0001870404","primary_entity_name":"CERO THERAPEUTICS HOLDINGS, INC."},"word_count":41,"has_tables":true,"body_markdown":"**Item 2.03 Creation of a Direct Financial Obligation\nor an Obligation under an Off-Balance Sheet Arrangement of a Registrant.**\n\n \n\nThe information set forth under Item 1.01 of this\nCurrent Report on Form 8-K is incorporated by reference into this Item 2.03."}